These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Effect of TSH-suppressive doses of levothyroxine on bone mineral density in Thai women. Ongphiphadhanakul B, Puavilai G, Rajatanavin R. J Med Assoc Thai; 1996 Sep; 79(9):563-7. PubMed ID: 8996984 [Abstract] [Full Text] [Related]
5. [Bone mineral density in patients on long-term therapy with levothyroxine]. Korsić M, Cvijetić S, Dekanić-Ozegović D, Bolanća S, Kozić B. Lijec Vjesn; 1998 May; 120(5):103-5. PubMed ID: 9748785 [Abstract] [Full Text] [Related]
6. The long term effect of levothyroxine on bone mineral density in patients with well differentiated thyroid carcinoma after treatment. Eftekhari M, Asadollahi A, Beiki D, Izadyar S, Gholamrezanezhad A, Assadi M, Fard-Esfahani A, Fallahi B, Takavar A, Saghari M. Hell J Nucl Med; 2008 May; 11(3):160-3. PubMed ID: 19081859 [Abstract] [Full Text] [Related]
7. Bone mineral density changes and bone turnover in thyroid carcinoma patients treated with supraphysiologic doses of thyroxine. Karner I, Hrgović Z, Sijanović S, Buković D, Klobucar A, Usadel KH, Fassbender WJ. Eur J Med Res; 2005 Nov 16; 10(11):480-8. PubMed ID: 16354602 [Abstract] [Full Text] [Related]
10. Bone mineral density during maintenance treatment with supraphysiological doses of levothyroxine in affective disorders: a longitudinal study. Bauer M, Fairbanks L, Berghöfer A, Hierholzer J, Bschor T, Baethge C, Rasgon N, Sasse J, Whybrow PC. J Affect Disord; 2004 Dec 16; 83(2-3):183-90. PubMed ID: 15555712 [Abstract] [Full Text] [Related]
12. Bone mineral density in women receiving thyroxine suppressive therapy for differentiated thyroid carcinoma. Chen CH, Chen JF, Yang BY, Liu RT, Tung SC, Chien WY, Lu YC, Kuo MC, Hsieh CJ, Wang PW. J Formos Med Assoc; 2004 Jun 16; 103(6):442-7. PubMed ID: 15278189 [Abstract] [Full Text] [Related]
13. Bone changes in pre- and postmenopausal women with thyroid cancer on levothyroxine therapy: evolution of axial and appendicular bone mass. Jódar E, Begoña López M, García L, Rigopoulou D, Martínez G, Hawkins F. Osteoporos Int; 1998 Jun 16; 8(4):311-6. PubMed ID: 10024900 [Abstract] [Full Text] [Related]
15. The relationship between serum dehydroepiandrosterone sulfate concentration and bone mineral density, lipids, and hormone replacement therapy in premenopausal and postmenopausal women. Osmanagaoglu MA, Okumuş B, Osmanagaoglu T, Bozkaya H. J Womens Health (Larchmt); 2004 Nov 16; 13(9):993-9. PubMed ID: 15665656 [Abstract] [Full Text] [Related]
16. Lack of deleterious effect on bone mineral density of long-term thyroxine suppressive therapy for differentiated thyroid carcinoma. Reverter JL, Holgado S, Alonso N, Salinas I, Granada ML, Sanmartí A. Endocr Relat Cancer; 2005 Dec 16; 12(4):973-81. PubMed ID: 16322336 [Abstract] [Full Text] [Related]
18. Low bone mineral density and high bone metabolism turnover in premenopausal women with unipolar depression. Petronijević M, Petronijević N, Ivković M, Stefanović D, Radonjić N, Glisić B, Ristić G, Damjanović A, Paunović V. Bone; 2008 Mar 16; 42(3):582-90. PubMed ID: 18226593 [Abstract] [Full Text] [Related]